Hany Massarany, President and CEO at GenMark Diagnostics, Inc. (GNMK), sold 6,010 shares at $7.39 ($44K) on 2018-08-21, disclosed to the SEC on 2018-08-22.
Open-market sale of $44k GNMK by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AXDX | BUY | 2022-02-01 | $66K | — | Filing → |
| AXDX | BUY | 2021-09-28 | $53K | — | Filing → |
| BDSX | BUY | 2020-11-03 | $135K | — | Filing → |